Corneal Collagen Cross-linking for Progressive Keratoconus
Status: | Completed |
---|---|
Conditions: | Dermatology |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | 14 - Any |
Updated: | 6/17/2018 |
Start Date: | December 2007 |
End Date: | April 2011 |
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus
Prospective, randomized multicenter study to determine the safety and effectiveness of
performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with
progressive keratoconus.
performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with
progressive keratoconus.
This was a sham controlled study for the first three months. Patients had one eye designated
as the study eye and were randomized to receive one of two study treatments (CXL or sham) in
their study eye. The patients were evaluated at 1, 3, 6, and 12 months. At month 3 or later
patients had the option of receiving CXL treatment in both the sham and non-study eye.
as the study eye and were randomized to receive one of two study treatments (CXL or sham) in
their study eye. The patients were evaluated at 1, 3, 6, and 12 months. At month 3 or later
patients had the option of receiving CXL treatment in both the sham and non-study eye.
Inclusion Criteria:
- Diagnosis of keratoconus
- Documented progression over previous 24 months
- Decreased BSCVA
- Must complete all study visits
Exclusion Criteria:
- Prior corneal surgery or Intacs
- History of delayed wound healing
We found this trial at
10
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials